Cortexyme, Inc. Gains 21.53%
Tue, Aug 10, 2021 at 05:30 PM
Cortexyme, Inc. (CRTX:NASDAQ) soared at $120.21, a gain of 21.5%. On Mon, Aug 09, 2021, CRTX:NASDAQ hit a New 2-Week High of $98.91. The stock appeared on our News Catalysts scanner on Mon, Aug 09, 2021 at 09:42 AM in the 'INVESTOR UPDATE' category. From Mon, Jul 26, 2021, the stock recorded 60.00% Up Days and 63.64% Green Days
About Cortexyme, Inc. (CRTX:NASDAQ)
Cortexyme Inc is a clinical stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis, or P. gingivalis, and its secreted toxic virulence factor proteases, called gingipains.
Top 10 Gainers:
- Fulcrum Therapeutics, Inc. (FULC:NASDAQ), 125.33%
- ZEV (ZEV:NYSE), 80.97%
- SC Health Corporation (SCPE:NYSE), 53.11%
- Mediaco Holding Inc. (MDIA:NASDAQ), 36.3%
- Exagen Inc. (XGN:NASDAQ), 24.59%
- ORPH (ORPH:NASDAQ), 24.58%
- ACHL (ACHL:NASDAQ), 22.13%
- FSR (FSR:NYSE), 21.56%
- Cortexyme, Inc. (CRTX:NASDAQ), 21.53%
- 3D Systems Corporation (DDD:NYSE), 21.48%